These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7940865)
1. Pretransplant removal of anti-HLA antibodies by plasmapheresis and continued suppression on cyclosporine-based therapy after heart-kidney transplant. Hodge EE; Klingman LL; Koo AP; Nally J; Hobbs RE; Stewart RW; Cook DJ Transplant Proc; 1994 Oct; 26(5):2750-1. PubMed ID: 7940865 [No Abstract] [Full Text] [Related]
2. [Plasmapheresis, immunosuppressive therapy and kidney transplant in a pre-sensitized patient]. Cuéllar-Cabrera H; Ramírez-Fernández M; Guerra-Rosales MJ; Sánchez-Avila MA Bol Med Hosp Infant Mex; 1989 Apr; 46(4):246-50. PubMed ID: 2655653 [TBL] [Abstract][Full Text] [Related]
3. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team. Martin S; Connolly J; Jos V Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295 [No Abstract] [Full Text] [Related]
4. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199 [TBL] [Abstract][Full Text] [Related]
6. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764 [TBL] [Abstract][Full Text] [Related]
7. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome. Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967 [TBL] [Abstract][Full Text] [Related]
8. Quantitative flow cytometry cross-matching for precise measurement of donor-specific alloreactivity. Cook DJ; Klingman LL; Koo AP; Goldfarb D; Dennis VW; Hodge EE Transplant Proc; 1994 Oct; 26(5):2866-7. PubMed ID: 7940904 [No Abstract] [Full Text] [Related]
9. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine. Sutherland DE; Moudry-Munns KC; Gruessner A Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866 [No Abstract] [Full Text] [Related]
10. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698 [TBL] [Abstract][Full Text] [Related]
11. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Torres MI; Luque J; Lorite P; Isla-Tejera B; Palomeque T; Aumente MD; Arizon J; Peña J Hum Immunol; 2009 Oct; 70(10):830-5. PubMed ID: 19638290 [TBL] [Abstract][Full Text] [Related]
13. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients]. Carl S; Wiesel M; Deiss JM; Daniel V; Opelz G; Staehler G J Urol (Paris); 1997; 103(1-2):7-9. PubMed ID: 9765770 [No Abstract] [Full Text] [Related]
14. Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis. Thielke J; DeChristopher PJ; Sankary H; Oberholzer J; Testa G; Benedetti E Transplant Proc; 2005 Mar; 37(2):643-4. PubMed ID: 15848486 [TBL] [Abstract][Full Text] [Related]
15. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
16. Use of bortezomib as adjunctive therapy for densensitization in combined heart and kidney transplantation--a case report. Patel JK; Everly MJ; Kittleson M; Kobashigawa JA Clin Transpl; 2009; ():347-9. PubMed ID: 20524297 [No Abstract] [Full Text] [Related]
17. Successful kidney transplantation after suppression of HLA alloantibodies with intravenous immunoglobulin in a highly sensitized patient. Wadström J; Gannedahl G; Bersztel A; Bengtsson M; Nättorp K; Mulec H Transplant Proc; 1995 Dec; 27(6):3463-4. PubMed ID: 8540052 [No Abstract] [Full Text] [Related]
18. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841 [TBL] [Abstract][Full Text] [Related]
19. Effect of plasmapheresis for acute humoral rejection after heart transplantation. Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369 [TBL] [Abstract][Full Text] [Related]